Status:

COMPLETED

Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery

Lead Sponsor:

Ruijin Hospital

Conditions:

Gastric Cancer

Anastomotic Leak

Eligibility:

All Genders

18-90 years

Brief Summary

We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.

Detailed Description

Anastomotic leakage after gastric cancer surgery is not very common but it is a very critical postoperative complication. Anastomotic leakage severely compromises the recovery after surgery. It increa...

Eligibility Criteria

Inclusion

  • Histologically confirmed gastric cancer
  • Patients who underwent radical gastrectomy

Exclusion

  • Patient who did not undergo gastrectomy

Key Trial Info

Start Date :

January 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 30 2019

Estimated Enrollment :

1049 Patients enrolled

Trial Details

Trial ID

NCT04490668

Start Date

January 1 2016

End Date

December 30 2019

Last Update

July 29 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.